Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Photochem Photobiol ; 90(4): 873-7, 2014.
Article in English | MEDLINE | ID: mdl-24502428

ABSTRACT

Mycosis fungoides (MF) and parapsoriasis (PP) are major dermatologic conditions for which phototherapy continues to be a successful and valuable treatment option. UVA-1 phototherapy is effective in the management of cutaneous T-cell mediated diseases. The aim of the study was to evaluate the efficacy and safety of low-dose UVA-1 phototherapy for the management of PP/early-stage MF. A total of 30 patients, diagnosed with MF (n:19) or PP (n:11) were enrolled to the study. All patients were managed with low-dose UVA-1 (20 or 30 J cm(-2)). Response was assessed clinically and immunohistochemically. UVA-1 treatment led to clinical and histological complete remission (CR) in 11 of 19 MF patients (57.9%), partial remission (PR) in three of 19 (15.8%), after a mean cumulative dose of 1665 (range, 860-3120) J cm(-2) and mean number of 73 exposure (range, 43-107) sessions. Five patients with PP (45.5%) showed CR, and PR was observed in six patients with PP (54.5%) after a mean cumulative dose of 1723 (range, 1060-3030) J cm(-2) and mean number of 74 exposure (range, 53-101) sessions. We conclude that low-dose UVA-1 therapy seems to be an effective, safe, and well-tolerated treatment option for patients with PP/early-stage MF.


Subject(s)
Mycosis Fungoides/radiotherapy , Parapsoriasis/radiotherapy , Phototherapy/methods , Ultraviolet Rays , Adult , Aged , Female , Humans , Male , Middle Aged
2.
An Bras Dermatol ; 88(2): 306-8, 2013.
Article in English | MEDLINE | ID: mdl-23739710

ABSTRACT

Whether parapsoriasis represents an early stage of T-cell cutaneous lymphoma is still the subject of controversy. We evaluated the efficacy of phototherapy in the treatment of parapsoriasis and its relation with TCCL. Patients diagnosed with parapsoriasis and treated with phototherapy PUVA or UVB-NB were selected. Between 1 to 8 years following treatment the evolution of their disease was evaluated. In 62 patients the cure rate was 79.3% and 17.2% showed improvement of the lesions. Only two patients developed full blown T-cell cutaneous lymphoma. Phototherapy is an excellent treatment for parapsoriasis, with high cure rates, regardless of the type of phototherapy employed. Of the 62 patients under study, parapsoriasis showed no general tendency to progress to T-cell cutaneous lymphoma.


Subject(s)
Parapsoriasis/radiotherapy , Ultraviolet Therapy/methods , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Lymphoma, T-Cell, Cutaneous/prevention & control , Male , Middle Aged , Skin Neoplasms/prevention & control , Treatment Outcome , Young Adult
7.
J Eur Acad Dermatol Venereol ; 20(5): 573-7, 2006 May.
Article in English | MEDLINE | ID: mdl-16684286

ABSTRACT

BACKGROUND: Narrowband UVB (NB-UVB) phototherapy has been shown to be effective for the treatment of various dermatoses. OBJECTIVE: To analyze the effects of NB-UVB phototherapy for small plaque parapsoriasis (SPP). METHODS: The response of 45 patients (24 females, 21 males, age range 20-58 years) with histologically confirmed SPP were assessed. NB-UVB therapy was given 3-4 times weekly. The initial treatment dose was 70% of the minimal erythema dose. The doses were increased gradually with a standard increment of 20/10/0. Clinical response was determined as follows: complete response (CR), at least 90% clearing of skin lesions; partial response (PR), at least 50% but less than 90% clearing and no response (NR), less than 50% clearing. The follow-up period was 6-24 months after the treatment. RESULTS: NB-UVB treatment led to CR in 33 of 45 patients (73.3%) with a mean cumulative dose of 14.3 J/cm(2) (range 3.2-24.1 J/cm(2)) after a mean number of 29 exposures (range 16-51 sessions); PR in 12 of 45 (26.6%) with a cumulative dose of 15.6 J/cm(2) (range 10.4-23.3 J/cm(2)) after a mean number of 29.4 exposures (range 25-50 sessions). Nineteen patients with CR had skin phototype II, 13 had type III and 1 had type I. Among the patients with PR, 7 had skin phototype II and 5 had type III. Postinflammatory hyperpigmentation was observed in 51% of the patients. Relapses occurred in six patients within a mean time of 7.5 months (2-12 months). CONCLUSION: NB-UVB phototherapy has several advantages over treatment with broadband UVB and PUVA. NB-UVB therapy for patients with SPP is an effective, safe and practical alternative treatment modality. Further larger studies with longer follow-up periods are necessary to determine the proper clinical response and long-term complications of NB-UVB therapy in this disease.


Subject(s)
Parapsoriasis/radiotherapy , Ultraviolet Therapy/methods , Adult , Aged , Dose-Response Relationship, Radiation , Female , Humans , Male , Middle Aged , Recurrence , Treatment Outcome
9.
Clin Exp Dermatol ; 30(4): 379-81, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15953075

ABSTRACT

Narrow band (311 nm) ultraviolet B (NB-UVB) has been shown to be a safe and effective treatment for psoriasis and other inflammatory skin diseases. We have therefore employed NB-UVB in the treatment of small plaque parapsoriasis (SPP) since 1996. All patients (16/16) responded with complete remission of the disease after a mean number of 32.8 exposures and a mean total dose of 35.4 J/cm2. Unwanted side-effects were rare (3.3%) and always mild. Relapse of the disease occurred after an average of 29 weeks in those patients who came for follow-up visits. Therefore, NB-UVB is an effective, comparably safe and convenient alternative to psoralen and ultraviolet A therapy or other treatment modalities in the suppression of SPP.


Subject(s)
Parapsoriasis/radiotherapy , Ultraviolet Therapy/methods , Adult , Aged , Dose Fractionation, Radiation , Female , Humans , Male , Middle Aged , Recurrence , Retrospective Studies , Treatment Outcome , Ultraviolet Therapy/adverse effects
11.
Arch Dermatol ; 135(11): 1377-80, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10566837

ABSTRACT

BACKGROUND: Broadband UV-B phototherapy has been used for many years in the treatment of small plaque parapsoriasis (SPP) and early-stage mycosis fungoides (MF). Our purpose was to investigate the effect on these diseases of narrowband (311-nm) UV-B therapy, which was recently established for the treatment of psoriasis and found to be more effective than broadband UV-B therapy. OBSERVATIONS: Twenty patients (5 women, 15 men; age range, 39-85 years) with histologically confirmed SPP or early-stage MF were enrolled. Six patients had early-stage MF (patch stage), and 14 had SPP. Treatment with 311-nm UV-B was given 3 to 4 times a week for 5 to 10 weeks. In 19 patients, lesions completely cleared after a mean number of 20 treatments (range, 14-29 treatments) and a mean cumulative UV-B dose of 16.3J/cm2 (range, 7.4-36.4 J/cm2) within a mean time of 6 weeks (range, 5-10 weeks). Biopsy specimens taken immediately after the end of phototherapy showed only sparse inflammatory infiltrates but no signs of SPP or MF. Relapses at cutaneous sites occurred in all patients within a mean time of 6 months (range, 2-15 months). CONCLUSIONS: Narrowband UV-B therapy is an effective short-term treatment modality for clearing SPP and early-stage MF. However, the treatment response did not sustain long-term remission. Further studies are necessary to examine how the clinical response to and follow-up after narrowband UV-B therapy compares with that of established phototherapy modalities in these diseases.


Subject(s)
Mycosis Fungoides/radiotherapy , Parapsoriasis/radiotherapy , Skin Neoplasms/radiotherapy , Ultraviolet Therapy/methods , Adult , Aged , Aged, 80 and over , Biopsy , Dose Fractionation, Radiation , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mycosis Fungoides/pathology , Neoplasm Recurrence, Local/pathology , Parapsoriasis/pathology , Radiotherapy Dosage , Recurrence , Remission Induction , Skin Neoplasms/pathology , Treatment Outcome
13.
Arch Dermatol ; 119(5): 378-80, 1983 May.
Article in English | MEDLINE | ID: mdl-6847216

ABSTRACT

Eleven patients with chronic pityriasis lichenoides chronica were treated with topically applied bland emollient cream and minimally erthemogenic doses of UV radiation from fluorescent sunlamps. The conditions of all patients cleared completely in an average of 29 treatments, requiring an average UV dose of 388 millijoules/sq cm at clearance. Phototherapy provides a convenient effective outpatient therapy for pityriasis lichenoides chronica.


Subject(s)
Parapsoriasis/radiotherapy , Ultraviolet Therapy , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Parapsoriasis/diagnosis , Radiotherapy Dosage
14.
J Am Acad Dermatol ; 6(3): 355-62, 1982 Mar.
Article in English | MEDLINE | ID: mdl-7068964

ABSTRACT

Thirty-one patients with early mycosis fungoides (MF) and three patients with parapsoriasis en plaques were treated with ultraviolet phototherapy (280 to 350 nm) at home using a commercially available light source containing four Westinghouse FS40 lamps. A complete clinical and histologic remission of disease, lasting for a median duration in excess of 18 months, was achieved in nineteen patients (61%) with MF. Although higher complete response rates generally are achieved with other therapeutic modalities, ultraviolet phototherapy with its minimal adverse effects may be indicated for selected patients. Controlled studies are encouraged to evaluate the full potential of conventional phototherapy in the management of MF.


Subject(s)
Mycosis Fungoides/radiotherapy , Skin Neoplasms/radiotherapy , Ultraviolet Therapy/methods , Adult , Aged , Biopsy , Female , Humans , Male , Middle Aged , Mycosis Fungoides/pathology , Neoplasm Recurrence, Local , Parapsoriasis/radiotherapy , Skin/pathology , Skin Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...